Curriculum Vitae
NAME: KEYUR H. PARIKH [ MD(USA), FCSI (India), FACC, FESC, FSCAI]
MOBILE : +91 -98250 - 26999.
CONTACT
DETAILS:
Office:
CIMS Hospital Pvt. Ltd.
Nr,Shukan Mall,
Off
Science City
Sola, Ahmedabad
– 380060 (
Mobile: +91
- 98250 66664, +91 98250 66668
Residence:
381-A,
17th lane, Satyagrah Chhavani
Ahmedabad – 380015 (
Tel / Fax: 91-079-26860456
Email keyur.parikh@cims.me
keyur.parikh@heartcareclinic.org
Website www.keyurparikh.com
www.cims.me www.indianheart.comContact Nos. in USA Tel: 1 862 251 4377
Birthplace
Date of Birth 18 – June – 1958
Nationality
Citizen of
Marital Status Married
Name of wife Reeta
Children Three
1. Shivam (Male) Age – 26 yrs (as in 2010)
2. Roosha (Female) Age – 23 yrs (as in 2010)
3. Parth (Male) Age – 18 yrs (as in 2010)
PRESENT
AFFILIATIONS / POSITIONS
As Cardiologist in
2. The Heart Care Clinic, Care Cardiovascular Consultants, Ahmedabad (2004 – till now)
3.
Sterling Hospitals,
4.
ACADEMIC
AND OTHER APPOINTMENTS
Chairman:
Care Institute of Medical Sciences (CIMS) (www.cims.me)
Chairman: Care Cardio Vascular Consultants
The Heart Care Clinic,
Trustee for Parikh CardioVascular Foundation (US Fed ID No.94-3213528) an organization serving philanthropy in the Healthcare
Trustee for Reeta Keyur Parikh Charitable Trust (Indian
Registration No. E/16549 Ahmedabad) an organization serving philanthropy
to widows, orphan children, disadvantaged women etc.
FORMER
AFFILIATIONS
As Cardiologist (
1.
2.
Director at
3.
4.
GRMI
(
As Cardiologist (
1.
2.
3.
As
Clinical Faculty (
Clinical
Instructor –
AWARDS
Ø
Awarded for:
o Commitment in cardiology in medically
developing or underdeveloped countries
o Having provided specific service to enhance
cardiovascular care and / or education in medically developing or
underdeveloped countries
o For continuous dedication to international
causes
o For being a role model for others to follow
The award is in recognition of the
contribution to the ACC and to the international cardiovascular community
Ø Included by Marquis Who’s Who Publications Board in “Who’s who in Medicine
and Healthcare”-Fifth edition, 2004-05
(Inclusion
limited to those individuals who have demonstrated outstanding achievement in
their own fields of endeavor and who have contributed significantly to the
betterment of contemporary society.)
Ø
Included by “Who’s Who in Medicine and Healthcare” for the year 2009-2010
Ø
Included by “Who’s
Who in World” for the year 2009-2010
Ø
Included by Marquis Who's Who Publications Board in "Who's who in Science and Engineering for the year 2010-2011
Ø
Ahmedabad
Medical Association (Branch of Indian Medical Association)
Awarded the “B.N. Mehta Oration-2002”, a yearly
oration awarded to distinguished doctors once a year, in
Ø Order of William Harvey Member of the “Order of William Harvey” (ACC, November 1991)
Ø Awarded by Indian Medical Association (HQS) for the "IMA DR. K. SHARAN CARDIOLOGY EXCELLENCE AWARD" for the year 2010
Ø Awarded by the International Academy of Cardiovascular Sciences, Winnipeg, Canada – "LIFETIME ACHIEVEMENT AWARD IN CARDIOVASCULAR SCIENCE, MEDICINE AND SURGERY" February 2011
Licensure:
State
of
AUTHORSHIP: Author of the book: “Hriday ni Vat Dil Thi”: Year of Publication 2006,
a 146 pages Book on heart diseases for lay person in Gujarati (Indian
Language).
Author
of the book: “Hriday ki Baat
Dil Se”: Year of Publication 2007, a
146 pages Book on heart diseases for lay person in Hindi (Indian Language).
Author of the book: “Heart to Heart”: Year
of Publication 2007, a 146 pages Book on heart diseases for lay person in
English.
PROFESSIONAL FELLOWSHIPS /
MEMBERSHIP
FCSI-Fellow of Cardiac Society of
FACC
– Fellow of American
FESC-Fellow of European Society of Cardiology,
FSCAI-
Fellow of Society for Cardiac Angiography and Interventions,
FIACS- Fellow of
Member of AMA –
Member of the Working Group on Pathogenesis of Atherosclerosis of the ESC.
Member of
EDUCATION
Fellowship
Residency:
Cardiovascular fellowship: Including Invasive and Noninvasive cardiology
July 1985 to June 1987 at
2 months of Echocardiography between 1983
-1985 at
Few months of clinical, Diagnostic & Inv. Electrophysiology At Kaiser Permanente, Panorama City and Good Samaritan Hospital, Los Angeles, California with Dr. David Cannom.
Residency in Internal Medicine: PGY -
2 & PGY - 3 (July 1983 to June 1985) at University of Southern
Internship in Internal Medicine (July 1982 to June 1983) Case Western University Affiliated Program - 4, St. Lukes Hospital, Cleveland, USA
Rotating
Housemanship:
Pre-Medical
Gujarat
College
Pre
– Science class at St. Xavier’s College Ahmedabad (
Schooling
St Xavier High School Ahmedabad (India) up to Class 11th Science & Mathematics (Major) received Grade “A+” (finished school certificate in the top 1%) - Stood among the top ten in the city.
Primary
School
ACADEMIC ACHIEVEMENTS
Medical Graduation
Bachelor
of Medicine & Bachelor of Surgery (M.B.B.S)
I to III M.B.B.S. - Grade “A+” from 1976-80.
Stood among the top three in class in all the three years.
III
M.B.B.S.
Distinction and “Gold Medal” in Obstetrics and Gynecology (1979-1980) and first in the College with highest marks in the theory paper of Medicine
II
M.B.B.S.
First in Pathology in the University (1978-79) and awarded “Dr. M. S. Kanvinde Gold Medal”
I M.B.B.S.
Distinction and all time University highest Marks (1977-78) and awarded Dr. Mehta Gold Medal in Anatomy
Pre-Medical
Course
First in the Class with all time highest marks in all subjects in all colleges
LEADERSHIP
International Advisor,
Reviewer, International Journal of Cardiology, an Elsevier publication
Director, Cardiovascular Department;
Chairman,
Cardiovascular Services,
Director,
Chairman, Care Cardiovascular Consultants Pvt. Ltd. (2001-till date)
Director,
Director,
Cardiac Catheterization Laboratory,
Chief
of Medicine (1991 - 1993) at
Chief of Cardiology /
Cardiac Catheterization Laboratory (1990 - 1991) at
PROFESSIONAL EXPERIENCE
Cardiac Interventions
- Over 30,000 Rt. Lt. cardiac catheterizations including complex coronary angiograms, valvular heart disease, grafts etc
- Over 8000 PTCA/PCI including complex multi-vessel grafts etc
- Coronary Stenting: Over 4000 stents used
- Coronary Directional Atherectomies
- Coronary High Speed Rotational Atherectomy/Ablations
- Coronary Intravascular Ultrasound studies
- Electrophysiology studies (SVT and V.Tachycardia, Mapping etc. and Ablations
- Endomyocardial Biopsies
- Permanent Pacemakers (Including Dual Chamber Rate Responsive Pacing etc.), Defibrillators etc
- M-Mode, 2-D Doppler. Stress Echo & Transesophageal Echocardiography.
- Innovative Devices: Ten successful cases of OVALUM-CiTop, 33 successful cases of ORBITAL ATHERECTOMY Device for calcific coronary arteries
- Ten successful cases of Neovasc Reducer® Coronary Sinus stent (a first in human trial) to evaluate the safety of the Neovasc Reducer™ in the treatment of Ischemic heart Disease (IHD), controlled narrowing of the coronary sinus
- Ten successful cases of Remon Impressure® Device placed in pulmonary artery (a first in human trial-PAPIRUS) to evaluate the safety of the Remon Impressure Device to measure Pulmonary artery pressure in heart failure patients responding to ultrasonic signals
Peripheral interventions
- Over 500 cases Peripheral Interventions. Complex lesion iliac, SFA Tibio- Peroneal A., Renal A., Subclavian A etc
- Over 100 Percutaneous Intra-Vascular Stenting Procedures including Iliac, Ilio-femoral, Abdominal Aorta Stents, Renal A., Subclavian and Brachiocephalic A etc
- Over 500 cases of Peripheral Diagnostic Angiography with Run-off
- Carotid Stenting / Use of Distal Protection Devices
TEACHING SEMINARS & CONFERENCES CONDUCTED TILL
DATE
ORGANIZING SECRETARY/CHAIRMAN
FOR:
Ø
CIMS-3C-Con 2011 (Feb1-6, 2011) – MS University , Baroda and Tagore Hall,
Ahmedabad: Organized by Care Institute Of Medical Sciences
& The Heart Care
Clinic, International Academy Of Cardiovascular Sciences,
International Society for Heart Research, Maharaja Sayajirao University
Of Baroda
Website: http://www.cimscon.com
Ø
3-C Con 2010 (Jan 9 - 11, 2009) – Tagore Hall,
Ahmedabad: Organized by The Heart Care
Clinic.
Website: http://www.indianheart.com/3ccon2010/images/First%20Announcement%20(17-3-2009)-4.pdf
Ø
3-C Con 2009 (Jan 9 - 11, 2009) – Tagore Hall,
Ahmedabad: Organized by The Heart Care
Clinic.
Website: http://www.indianheart.com/3-C%20Con%202009%20Pocket%20Planner.pdf
Ø
3-C Con 2008 (Jan 11- 13, 2008) – Tagore Hall,
Ahmedabad: Organized by The Heart Care
Clinic.
Website: http://www.indianheart.com/3-C%20Con%202008.pdf
Ø
3-C Con 2007 (Jan 26 – 28, 2007) – “Recent
Updates in Cardiovascular Medicine”, Tagore Hall, Ahmedabad: Organized
by The Heart Care Clinic.
Website: http://www.indianheart.com/3-C%20Con%202007.pdf
Ø
3-C Con 2006-”Novelties and Advances in
Cardiovascular Medicine”,
Website: http://www.indianheart.com/3-C%20Con%202006.pdf
Ø
“Joint
International Conference” (JIC) -2005, 31st Dec 2004 to 2nd
Jan 2005.( 800 + delegates conference with over 50 International Faculty)
Website: http://www.indianheart.com/JIC-2005.pdf
The
Conferences was jointly organized by:
1) Care Cardiovascular Consultants
2)
3)
International Society for Heart Research (
In Association with:
4) American Association of Physicians of Indian Origin (AAPI)
5) American Association of Cardiologists of Indian Origin (AACIO)
TEACHING SEMINARS CONDUCTED
Year 2002 – 2006
Course Director in the following Major CME
programs in Ahmedabad
·
Symposium:
Emerging Concepts in Cardiology,
24 & 25 Jan. 2004 and 4 & 5 Sep. 2004
·
Seminar
on Congenital Heart Disease, 25
Jul. 2004 and 11 Dec. 2004
·
Symposium:
EKG, Arrhythmias & EP Studies,
21 & 22 Feb. 2004 and 9 & 10 Oct. 2004
·
Comprehensive
CPR & Critical Care Course,
20& 21 Mar. 2004 and 14 & 15 Aug 2004
·
Comprehensive
Echocardiology Course, 3 & 4
Jan 2004 and 10 & 11 Jul 2004
·
Comprehensive Arrhythmia and Interventional
Electrophysiology - 11 & 12 January
2003
· Basic and Advanced Course in Cardiopulmonary Resuscitation Feb 8 & 9, 2003
· Symposium and Update in Cardiovascular Disease, March 8 & 9, 2003
· Comprehensive ECG, Arrhythmias & Electro-Physiology Course, April 26 & 27, 2003
· Comprehensive Echocardiography Course, June 27, 28 & 29, 2003
·
Updates in Congenital Heart Disease, July 13, 2003
·
Updates in Cardiology for Family Physicians , 20 July 2003
· Symposium and Update in Cardiovascular Disease, August 2 & 3, 2003
·
Comprehensive ECG, Arrhythmias &
Electro-Physiology Course, August 30
& 31, 2003
·
Cardio-Pulmonary Resuscitation and Critical
Care, September 13 & 14, 2003
·
Symposium and Update in Cardiovascular Disease, September 27 & 28, 2003
·
Comprehensive ECG, Arrhythmias &
Electro-Physiology Course, November 8
& 9, 2003
·
Cardio-Pulmonary Resuscitation and Critical
Care, November 22 & 23, 2003
·
Updates in Congenital Heart Disease, December 13 & 14, 2003
· Symposium and Update in Cardiovascular Disease - 10 & 11 August 2002
· Symposium and Update in Cardiovascular Disease - 14 & 15 September 2002
· Advances in Pediatric Cardiology - 17 Nov 2002
· Symposium and Update in Cardiovascular Disease - 21 & 22 December 2002
1995-2004
Organized
over 30 conferences in
1994-2003
Guest Speaker at
Multiple Conferences and talks in
1997
International
Proctor to demonstrate the use of Wiktor Stent (Medtronic) in
January
1994
·
Conducted live/hands-on workshop in
Interventional Cardiology at
·
Conducted live/hands-on workshop in
Interventional Cardiology at
·
Conducted live/hands- on workshop in
Interventional Cardiology at
·
Conducted live/hands –on workshop in
Interventional Cardiology at PGI,
·
Conducted live/hands- on workshop in
Interventional Cardiology at
·
Conducted live/hands – on workshop in
Interventional Cardiology at C M C Medical Center,
June-July 1993
·
Conducted live/hands on workshop in
Interventional Cardiology at
·
Conducted live/hands – on workshop in
Interventional Cardiology at
·
Conducted live/hands-on workshop in
Interventional Cardiology at Nizam Institute of Medical Science,
·
Intra Vascular Peripheral Stents were used in
Conducted live / hands-on workshops
in Interventional Cardiology at
May
1992
Interventional
Cardiology-live/hands on course at Post Graduate Institute,
Visiting Lectures/Talks
in Mumbai,
November
1992
Conducted live/hands –
on workshop in Interventional Cardiology at Railway Hospital, Chennai with
Dr K.A. Abraham Conducted live/hands-on workshop in Interventional Cardiology
at P.G.I, Chennai
Conducted live/hands on
workshop in Interventional Cardiology at Bombay Hospital, Mumbai with Dr. Pereira Visiting Lectures
in Bombay, Bangalore and Chennai
·
Visiting Lectures and Demonstrations of Video
taped cases at Mumbai, Jaipur,
1988 – 1991
Peripheral Angioplasty in Mumbai, at President
Hotel, sponsored by Dr.
Navin Nanda in
December 1988
Coronary Angioplasty in Ahmedabad in
December 1988
Controversies
in C.H.F. in Ahmedabad at
FACULTY
IN NATIONAL & INTERNATIONAL CONFERENCES
·
Invited as Faculty C3 Capital Cardiovascular Conference, June 20-24,
2010,
Ø
Promise of Novel Antiplatelet Agents : Insights From
TRITON TIMI 38 and PLATO Trials, How We Should Change Our Practice In
ACS PCI ?
Ø
Is Manual Extraction A Necessary Adjunct For The STEMI Patient?
·
Invited as Clinical Faculty for TCT 2009,
September 21-26, 2009,
Faculty with following talks:
Ø The Ovalum CiTop Guidewire System: Device
Evolution, Peripheral and Coronary Applications
Ø Case Presentation: Orbital Atherectomy and
Calcified Coronary Lesions
·
Invited as Faculty C3 Capital Cardiovascular Conference,
June 14-17, 2009,
Faculty with following talks:
Ø Orbital Atherectomy: Preliminary Experience
in Calcific Coronary Artery Disease
Ø Should Mechanical Aspiration Be the Standard
of Care in Thrombus – Containing lesions?
·
Chronic Total Occlusion
Faculty with following talks:
Ø Ovalum CiTop: FIM Results and Early
Clinical Experience
·
ICI 2008: December 7-9, 2008,
Faculty with following talks:
Ø Revisiting Thrombus Extraction in Primary
Percutaneous Coronary Intervention
Ø First-In-Man Results with the Ovalum CiTopTM
ExPander TM Guidewire in Chronic Total Occlusions
·
TCT 2008: October 13-17th 2008,
Faculty with the following talks:
Ø Basic and Expert Techniques IX: Utility and
Development of Novel Devices for CTO Applications: The Ovalum CiTop Guidewire
System: FIM Coronary CTO Results
Ø Cardiac Pressure Monitoring Devices:
Device-based Approaches for Heart Failure II: Emerging Interventional
Technologies (REMON)
Ø Plaque Modification and Debulking in the
Coronary and Peripheral Circulations: Atherectomy and Laser Rotational
Atherectomy 2008: Orbital Atherectomy for de novo Calcified Coronary Lesions:
The ORBIT I FIM Study
·
European
Society of Cardiology Annual Scientific Congress-2008,
·
Chronic Total Occlusion
Faculty
with the following talks:
Ø Section Title: Revisiting Blunt
Microdissection Topic: First-in-Man Results with the Ovalum CiTop Guidewire System
·
ICI 2007: December 03-04th
2007,
Faculty
with the following talks:
Ø Section Title: Globalizing Clinical Research
Topic: New Frontiers
Ø Section Title: New frontiers in Chronic
Total Occlusions Topic: CiTopTM guidewire
·
TCT 2007: October 21-24th 2007,
Faculty
with the following talks:
Ø Section Title: CTO Imaging and Novel Device
Approach Topic: Blunt Microdissection Revisited: The Ovalum CiTop Guide Wire
System
Ø Section Title: A Potpourri of Innovative
Devices and Futuristic Therapies Topic: The Neovasc Coronary Sinus REDUCER for
Refractory Ischemia: Clinical Trial Update and Future Plans
Ø Section Title- Cardiac Monitoring Devices
for CHF Topic: Clinical Studies With a Pulmonary Artery Pressure Sensor I:
Ramon Medical
·
DCRI: October 23rd 2007, Duke,
Faculty
with the following talks:
Ø
New
Frontiers in Clinical Research:
·
European
Society of Cardiology Annual Scientific Congress-2007,
·
56th
·
55th
·
“Innovations in Cardiovascular Interventions-ICI-2006”, Dec3-5, 2006, Tel
Speaker: Global Device Evaluation: Can Intervention in
First in man Pilot study using
the REMON ultrasonic intravascular sensor to
measure Pulmonary Artery
Pressure
·
TCT 2006:
Oct 22-27, 2006,
·
TCT 2005: October 15-21st October,2005
Faculty
with the following talks:
Ø First in man Pilot study using the REMON
ultrasonic Intravascular sensor to measure
Pulmonary Artery Pressure
Ø Preliminary Clinical Experience with the
NEOVASC coronary Sinus Reducer Stent
·
“World
Congress of Cardiology-ESC 2006” Sept 2-6, 2006 at
·
ESC Congress 2005,
Chairperson: “Percutaneous intervention in
high-risk clinical subset”
·
Euro-PCR:
2005,
Joint session
Euro PCR & TCT
DES in complex lesions:
Review of cases performed during Euro PCR & CRF archives
·
Association of Physicians of
Speaker:
(1) “Statins-Newer Insights”
(2) “CAD-Current Concepts
and future directions”
Faculty in National Conferences:
·
CSI 2006,
Speaker: (1) “Management of complex Dyslipidemias”
(2) “Heart Failure 2006: Triumphs & Tribulations”
·
CSI
2005,
1. Speaker: “Stem cells – Healing the damaged heart – Myth, Hype and Reality”
2. Symposium: “Group Practice in Cardiology” – Research & Financial Planning in group practice
·
CSI 2004,
1. Speaker:” The revision in ATP-III guidelines-2004”
2. Chairperson: “Coronary Stents Update”
·
CSI 2000,
1. Speaker: “HPCR Guidelines for Heart Failure”
2. Speaker: “Ischaemic Heart Disease Endothelial Dysfunction”
CONDUCTED
WORKSHOPS IN
Ø Spring/Post-ACC Workshop in Interventional Cardiology and Peripheral work from March 21-24, 1994
Ø Fall Workshop in Interventional Cardiology and Electrophysiology from September 26 to 30, 1994
Ø Fall Workshop in Interventional Cardiology and Electro physiology from November 7-11, 1993
Ø Summer Workshop in Interventional cardiology and EPS in August 1993
Ø Spring Workshop in PTCA, DCA and Permanent Pacemakers, Electrophysiology & Radiofrequency ablations etc in March 1993
CLINICAL TRIALS
INTERNATIONAL CLINICAL TRIALS
|
1 |
Principal Investigator for RUBY registry (For India) (2002) |
To
evaluate Percusurge / Guardwire Distal Protection Device (Presented
by Dr. Aman, |
Presented TCT October 2003, Sponsored by Medtronics Pvt. Ltd. |
|
2 |
Principal Investigator at |
Enoxaparin and
Thrombolysis Reperfusion for Acute Myocardial Infarction
Treatment Thrombolysis in Myocardial Infarction
–Study 25 |
Presented at ACC 06 |
|
3 |
Principal Investigator for
OASIS-5 Trial (2004) |
To evaluate the
efficacy and safety of fondaparinux versus Enoxaparin in the acute
treatment of unstable angina or non ST-segment
elevation myocardial infarction acute coronary syndromes |
Presented in ESC, |
|
4 |
Principal Investigator for
OASIS-6 Trial (2004) |
To evaluate the
efficacy and safety of fondaparinux sodium versus control therapy
and Glucose-Insulin-Potassium infusion versus control
in broad range in patients with ST - segment elevation acute
myocardial infarction |
Presented at ACC 06 |
|
5 |
Principal Investigator for TRUST Trial (2004) |
To evaluate the safety
and efficacy of intravenous Remodulin® in patients( in (PAH)
|
Trial completed |
|
6 |
Co-Investigator for Paediatric Hypertension Trial (2005) |
Dose ranging study to evaluate the safety and efficacy of Olmesartan medoxomil in children and adolescents
with hypertension |
Trial completed |
|
7 |
Principal Investigator for Hypercholesterol study (NK-104-301) at The
Heart Care Clinic (2005) |
Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg
and Pitavastatin 4 mg vs. Atorvastatin 20 mg
(Following Up Titration ) in Patients with Primary
Hypercholesterolemia Or Combined Dyslipidemia |
Trial completed |
|
8 |
Principal Investigator for Neovasc Reducer™ Pilot Study, First
in human: (2005) |
To evaluate the safety of the Neovasc Reducer™ in the treatment of Ischemic
coronary sinus
|
Presented at TCT, 2005 |
|
9 |
Principal Investigator For PAPIRUS Trial: Pilot Study, First in
Human: |
Monitoring Pulmonary Artery Pressure by
Implantable Device Responding to Ultrasonic Signal(REMON Device) |
Trial completed |
|
10 |
Principal Investigator for Export study (2006) |
Flow
improvement in patients with Acute Myocardial Infarction undergoing either
conventional stenting or a strategy of primary aspiration followed by
stenting using the Export® Aspiration Catheter: a Prospective, Randomized,
Controlled Study |
Trial completed |
|
11 |
Principal Investigator for E-five registry (for |
To Evaluate the ‘Real
World’ Clinical Performance of the Medtronic Endeavor™ ABT-578 Eluting
Coronary Stent System. |
Trial completed |
|
12 |
Co- Investigator for RELY study (2006) |
Randomized
Evaluation of Long term anticoagulant therapy comparing
efficacy and safety of two blinded doses of dabigatran
etexilate with open label warfarin for the prevention of
stroke and systemic embolism in patients with non-valvular atrial
fibrillation : prospective, multi-centre, Parallel group,
non-inferiority trial. |
Trial completed |
|
13 |
Principal Investigator for Hypercholesterolemia study (NK-104-307) at
The Heart Care Clinic (2006) |
Open label, long-Term (1year) extension study of Pitavastatin 4 mg QD in patients with Primary Hypercholesterolemia or
combined
|
Trial completed |
|
14 |
Principal Investigator for e-SELECT Registry (2007) |
The e-SELECT Registry : A Multicenter Post
Marketing Survelliance |
Trial
completed, follow-ups ongoing |
|
15 |
Principal Investigator for
Early ACS trial (2007) |
Early Glycoprotein Iib/IIIa Inhibition in
Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized,
Placebo-Controlled Trial Evaluating the Clinical Benefits of Early
Front-loaded Eptifibatide in the
Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome
(EARLY ACS) |
Follow-ups ongoing |
|
16 |
Principal Investigator
for PLATO trial (2007). |
A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and safety study of AZD6140 Compares with Clopidogrel for prevention of Vascular Events in patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of
PLATelet inhibition and Patient Outcomes.] |
Trial completed |
|
17 |
Principal Investigator
for OASIS- 7 trial (2007) |
Randomized, multinational, double-blind study, comparing a high
loading dose regimen of Clopidogrel versus standard dose in patients with
unstable angina or non-ST segment elevation myocardial infarction managed
with an early invasive strategy |
Trial completed |
|
18 |
Principal Investigator for New Guidewire (2007) |
First in Man: A Feasibility study to evaluate safety and efficacy of
New Guidewire for Crossing Total Occlusions in Coronary Arteries |
Trial completed |
|
19 |
Co-Investigator for Paediatric Hypertension Trial, The Heart Care
Clinic, Ahmedabad (2007) |
A Randomized, double blind, Placebo-Controlled, Multicenter, Parallel
Study Assessing the Efficacy, Safety, and Dose Response of Ramipril for the
Treatment of Hypertension in Children and Adolescents |
Trial completed |
|
20 |
Co-Investigator for Aristotle Trial at The Heart Care Clinic,
Ahmedabad (2007) |
Apixaban for reduction in stroke and other thromboembolic events in
atrial fibrillation: Active controlled randomized double blind parallel arm study to evaluate efficacy and safety
of Apixaban in subject with non
valvular Atrial fibrillation |
Ongoing |
|
21 |
Co-Investigator for Rocket Trial at The Heart Care Clinic, Ahmedabad
(2007) |
Multicenter, Randomized, double-blind – dummy, Parallel-group,
Non-inferiority Trial Comparing the Efficacy and Safety of Once-daily oral
Rivaroxabab (BAY 59-7939) with Adjusted-dose oral Warfarin for the prevention
of Stroke and Non-central-nervous-system systemic embolism in Subjects with
Non-valvular Atrial Fibrillation |
Ongoing |
|
22 |
Principal Investigator for PROTECT Trial (2007) |
Patient Related Outcomes with Endeavor versus Cypher stenting Trial:
Prospective, multicenter, randomized, two-arm, open-label trial |
Follow-ups ongoing |
|
23 |
Principal Investigator for TMC-CAN-05-02 (2007) |
A clinical trial comparing Cangrelor to Clopidogrel in subject who
require Percutaneous Coronary Intervention |
Follow-ups ongoing |
|
24 |
Principal Investigator for TMC-CAN-05-03 (2008) |
A clinical Trial comparing treatment with Cangrelor (in combination
with usual care) to usual care in subjects who require Percutaneous Coronary
Intervention |
Follow-ups ongoing |
|
25 |
Principal Investigator for CL
(Ivabradine) at The Heart Care Clinic (2008) |
Evaluation of the anti-anginal efficacy |
Ongoing |
|
26 |
Principal
Investigator for RE-DEEM at The Heart
Care Clinic (2008) |
Randomized Dabigatran Etexilate dose finding study in patients with
acute coronary syndromes post index Event with additional risk factors for cardiovascular
complications also receiving aspirin and clopidogrel: Multi-centre,
prospective, placebo controlled, group dose escalation trial |
Trial completed |
|
27 |
Co-Investigator for Magellan Trial (2008) |
A Multicenter, Randomized, parallel-group efficacy superiority study
in hospitalize medically ill patients comparing rivaroxaban with Enoxaparin |
Ongoing |
|
28 |
Co-Investigator
for Borealis Trial at The Heart Care Clinic Ahmedabad (2008) |
A multicenter, randomized, double-blind, assessor-blind,
non-inferiority study comparing the efficacy and safety of once-weekly
subcutaneous biotinylated idraparinux (SSR126517E) with oral adjusted-dose
warfarin in the prevention of stroke and systemic thromboembolic events in
patient with atrial fibrillation |
Ongoing |
|
29 |
Principal
Investigator for Freedom-PAH at The Heart Care Clinic |
FREEDOM UT –15C Studies (TDE-PH-302 and
TDE-PH-304) conducted by United Therapeutics. |
Ongoing |
|
30 |
Principal
Investigator for ORBIT – 1 |
Pilot study to evaluate the safety & performance or the diamond
back 360TM orbit Atherectomy system in treating de-NOVO calcified coronary
lesions – orbit -1 |
Trial completed |
|
31 |
Co-Investigator
for AVERROES at The Heart Care Clinic |
CV 185-048: A Phase 3, Active (Aspirin) Controlled, Randomized,
Double-Blind, Parallel arm Study to Evaluate the Efficacy and Safety of
Apixaban in Preventing Stroke and Systemic Embolism in Patients with
Nonvalvular Atrial Fibrillation |
Ongoing |
|
32 |
Principal
Investigator for Red-HF at The Heart Care Clinic |
A Double-blind, Randomized, Placebo-controlled,
Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa
Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with
Symptomatic Left Ventricular Systolic Dysfunction and Anemia – 20050222 Amendment 1. |
Ongoing |
|
33. |
Principal
Investigator for TAK-442-202 at The Heart Care Clinic |
A Phase II, double-blind, Randomized,
Placebo-controlled study of the safety and Efficacy of TAK-442 in subjects
with Acute Coronary Syndrome. |
Trial completed |
|
34. |
Principal
Investigator for EISAI-202 at The Heart Care Clinic |
A Randomized, Double-Blind Placebo controlled
study of the safety and tolerability of E5555 and its effect on clinical
event and biomarkers in patient with |
Trial completed |
|
35 |
Co-Investigator
for E-Resolute at the Heart Care Clinic |
Evaluation of the Endeavor Resolute
Zolarolumes-Eluting Coronary Stent System in a ‘Real World’ Patient
Population. |
Follow-up ongoing |
|
36 |
Principal
Investigator of RIVAROXABAN at The Heart Care Clinic |
Randomized, Double Blind, Placebo
Controlled, Event Driven, |
Ongoing |
|
37 |
Principal
Investigator of Pfizer PAH at The Heart Care Clinic B1321001 |
A Phase 3, |
Ongoing |
|
38 |
Principal
Investigator of Pfizer PAH at The Heart Care Clinic B1321002 |
A Phase 3, Multi Center, Open Label Study
To Evaluate The Long Term Safety Of Monotherapy Sitaxsentan Sodium And
Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In
Subjects With Pulmonary Arterial Hypertension. |
Ongoing |
|
39 |
Principal
Investigator of Pfizer PAH at The Heart Care Clinic B1321003 |
A Phase 3, Multi Center, Randomized, Double
Blind, Efficacy And Safety Study Of Monotherapy Sitaxsentan Sodium Versus
Combination Therapy With Sitaxsentan Sodium and Sildenafil Citrate In
Subjects With Pulmonary Arterial Hypertension Who Have Completed Study
B1321001. |
Ongoing |
|
40 |
Principal
Investigator of LPL STABILITY at The Heart Care Clinic |
A Clinical Outcome Study Of Darapladib
Versus Placebo In Subjects With Chronic Coronary Heart Disease To Compare The
Incidence Of Major Adverse Cardiovascular Event. (MACE) |
Ongoing |
|
41 |
Principal
Investigator of OASIS-8 at The Heart Care Clinic |
A Prospective Study Evaluating The Safety
Of Two Regimens Of Adjustive Intravenous UFH PCI In High Risk Patients With
UA/NSTEMI Initially Treated With Subcutaneous Fondaparinux And Referred For
Early Coronary Angiography. |
Ongoing |
|
42 |
Co-Investigator of
STEM CELL |
A Randomized, Double Blind, Multi Centric,
Placebo Controlled, Single Dose, Phase I/II Study Assessing The Safety And
Efficacy Of Intravenous Ex Vivo Cultured Adult Allogenic Mesenchymal Stem
Cell In Patients With ST Elevated Acute MI
(STEMI) Patient. |
Ongoing |
|
4
3
|
Principal Investigator for RUBY 1Trial at The
Heart Care Clinic Ahmedabad (2010) |
A Randomized, Double Blind, Placebo
Controlled, and Parallel Group Study of the Safety,
Tolerability, and Efficacy of YM150 in combination with Standard Treatment in Secondary Prevention of Ischemic Vascular Events in
Subjects with Acute Coronary Syndromes. |
Ongoing |
|
4
4
|
Principal Investigator for AmarinTrial at The
Heart Care Clinic Ahmedabad (2010) |
A phase 3, multi center, placebo controlled, randomized, double blind,
the efficacy
triglyceride levels
|
Ongoing |
|
4
5
|
Principal Investigator for AmarinTrial at The
Heart Care Clinic Ahmedabad (2010) |
A Phase III, Randomized, Double Blind, Evaluation Of The Safety And Efficacy Of Apixaban In Subjects With A Recent Acute Coronary Syndrome.
|
Ongoing |
|
4
6
|
Co Investigator for SASHF RTrial at The
Heart Care Clinic Ahmedabad (2008) |
South Asian Systolic Heart Failure Registry |
Ongoing |
|
47
|
Co Investigator for TRAC HF Trial at The
Heart Care Clinic Ahmedabad (2009) |
TRAC HF: Ambulatory Monitoring Using External Physiological
|
Trial Complete
|
|
48
|
Co Investigator for DOT HF Trial At The Heart Care Clinic/ CIMS, Ahmedabad (2009)
|
DOT - HF Diagnostic Outcome Trial In Heart Failure |
Trial Complete
|
|
49
|
Co Investigator for T BEST D Trial At The Heart Care Clinic/ CIMS, Ahmedabad (2009)
|
T-BEST -D : Temporary Bronchial Epicardial Stimulation - Defibrillation Clinical Study Version Dated : June 28, 2009 |
Trial Complete
|
|
50
|
Co Investigator for ALECARDIO Trial At The Heart Care Clinic/ CIMS, Ahmedabad (2010)
|
A Phase 3 Multicenter, randomized, double-blind, parallel group, placebo controlled study cardiovascular outcome study to evalute the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D) |
Ongoing |
|
51
|
Principal Investigator for TIMI 52 Trial at The Heart Care Clinic / CIMS Ahmadabad (2010)
|
A phase 3 multicenter, randomized, double-blind, parallel group, placebo controlled Study of Darapladib versrsus Placebo in Subject Following Acute Coronary Syndrome to compare the Incidence of Major Adverse Cardiovascular Events
|
Ongoing |
|
52 |
Principle Investigator for SOLISTICE trial at CIMS Hospital Ahmadabad (2011) (2010)
|
A Randomized ,double-blind, placebo-controlled study yo evaluate the safety of 12 weeks of dosing with GW856553 and its effects on inflammatory markers, infaraction without ST segment elevation |
Ongoing |
|
53
|
Principle Investigator for CANVAS study at CIMS Hospital Ahmadabad (2011)
|
A Randonriz-ed. Doublc-lllintl. I'arallt'1. Placebo-Controlled, Multicenter Study of the Effects of JNJ- 28431754 t-rn Cardiovascular Outcotrte: Adult Subjects With Type 2 Diabetes Mellitus. The CANVAS Trial (CANaglil'lozin Cardio Vascular Assessment Study) |
Ongoing |
|
54 |
Co Investigator of study ATTAIN at CIMS Hospital Ahmadabad (2011)
|
a prospective, non-randomized, multi-center, post-market, global clinical trial to assess left-heart lead implant and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.
|
Ongoing |
|
55 |
Principle Investigator for TIMI 53 ( SAVOUR ) CIMS Hospital Ahmadabad (2011)
|
A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Phase IV Trial to Evaluate the effect of Sexagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in patient with Type 2 Diabetes)
|
Ongoing |
|
56
|
Co Investigator of study OPTIMIND at CIMS Hospital Ahmedabad (2011)
|
Clinical Outcome of Pacemaker pallets according to pacing Modality and primary Indications
|
Ongoing |
|
57
|
Co Investigator of study SST at CIMS Hospital Ahmedabad (2011)
|
The Pain free SST (Smart Shock Technology) clinical Study. |
Ongoing |
NATIONAL CLINICAL TRIALS
|
1 |
Principal Investigator for BIVAFLO Registy
(2006) |
To evaluate the
efficacy and safety of BIVAFLO® as an adjunctive therapy
during PCI in moderate-high risk ACS patients with
provisional GP IIb/IIIa inhibitors use. |
Trial completed |
|
2 |
Principal Investigator for CORREL + C
Trial (2006) |
The
COREL C Registry : A multicentre Post
marketing Survelliance for clinical and angiographic evaluation of
Corel C stent |
Trial completed |
|
3 |
Principal Investigator for POLYCAP Trial at
The Heart Care Clinic Ahmedabad(2007) |
A
randomized double blind controlled trial of the efficacy And
safety of POLYCAP Vs its components in subjects With
atleast one additional cardiovascular risk factor |
Trial completed |
|
4 |
Principal Investigator for ACUNOVA Trial (2006-2007) |
A
phase III, open label, multicentric, parallel group, Randomized
study to evaluate the safety and efficacy of Abciximab
in Indian patients scheduled for Percutaneuos Coronary
Intervention. |
Trial completed |
|
5 |
Principal Investigator for ZYHI Trial at The
Heart Care Clinic Ahmedabad (2007) |
(1) A randomized, double blind parallel group, prospective dose ranging
the efficacy
No. 2001 Ver: 01
prospective dose ranging
arm to
evaluate the efficacy
diabetes Protocol No.
2003 Ver: 02
(3) A randomized, double blind parallel group, prospective dose ranging
the efficacy
test Protocol No.2004 Ver: 02
|
Trial completed |
NATIONAL &
INTERNATIONAL PUBLICATIONS
|
|
Authors |
Title |
Place, year and type of Publication/Presentation |
|
1 |
Uri Elkayam, Keyur Parikh, Shahbudin Rahimtoola |
Absence
of effect of Diltiazem on Digoxin Serum Concentration and Renal clearance in Patients with Cardiac
Disease |
JACC, 1985 Vol 5, No.2, Part 2 Page 419(Abstract) |
|
2 |
Uri Elkayam, Keyur Parikh, Behrooz Torkan, Laura Weber, Jorden Cohen, Shahbudin Rahimtoola |
Effect of Diltiazem on Renal Clearance and Serum Concentration of Digoxin in patients with Cardiac Disease |
JACC 1985 Vol 29 |
|
3 |
Keyur Parikh, Peter
Mahrer Amar Kapoor |
Subsets of Left Main Coronary Artery Disease: Clinical and Impact on Artery Disease: Clinical and Impact on Survival Correlating with Angiographic Data” |
1985 – 1987 |
|
4 |
Keyur Parikh, Peter Mahrer, Kaiser Hospital,
Los Angeles |
Clinical Profiles of Atrial Myxomas |
Cardiovascular Review And Reports (1987) |
|
5 |
K H Parikh et al |
Use
of Abciximab (Reopro): In High Risk Coronary Artery Disease Patients during
angioplasty and Stents |
|
|
6 |
K H Parikh |
HCPR
Guidelines for Heart Failure Therapeutics |
IHJ, 2000 Vol 52, No. 6 |
|
7 |
K H Parikh (CSI) |
Ischemic
Heart Disease Endothelial Dysfunction |
IHJ,2000 Vol 52, No.6 |
|
8 |
Keyur Parikh (CSI) |
|
Indian Heart Journal |
|
9 |
Parikh
KH, Chag M C, Shah UG, Baxi H A, Chandarana AH, Naik A M, Shah KJ |
Acute Results and
Intermediate term Follow-up of PCI
with cardio protection by balloon occlusion Distal Protection Device
(Abstract) |
IHJ
J-233, 2002 54:561-568 |
|
10 |
Shah H, Iyer S, Mehta K, Parikh K, Jain A, Goyal RK |
Pharmaco-epidemology
and risk factors of Hypertension in |
Indian Journal of Pharmacology 2003; 35(4); pg 277 |
|
11 |
Parikh
KH, Shah KJ, Chag M C, Shah U G, Baxi H A, Chandarana A H, Naik A M, Goyal RK |
Reversal
of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and
sodium nitroprusside, in
combination |
JACC
March 19, 2003, Suppl.A to 54:561-568, Vol.41, Issue – 6 |
|
12 |
Shah K J, Parikh K H, Chag M C,Shah U
G, Baxi H A, Chandarana A H, Naik A M, Goyal R K |
Prevalence of Hyper–homocysteinemia in
Western Indian Population with or without Coronary Artery Disease |
Indian Journal of Cardiology;Vol 6;2003;
54-58. |
|
13 |
Parikh KH, Shah KJ, Chag MC, Shah UG, Baxi HA, Chandarana
AH, Naik A M, Goyal RK |
Reversal
of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and
sodium nitroprusside in combination |
Suppl. To JACC, Mar 19,
2003; 41(6), Suppl.A-1101-201.
|
|
14 |
Parikh KH,Chag MC, Shah UG, Baxi HA,
Chandarana AH, Naik AM, Shah HD, Goyal RK |
Beneficial effects of distal protection device in
Reducing the use of intracoronary vasodilators And glycoprotein IIb/IIIa receptor antagonists During percutaneous coronary interventions. |
Catheterization and Cardiovascular
Interventions 2004; 62: pg 90. (Abstract) |
|
15 |
Parikh KH, Chag MC, Shah UG, Baxi HA,
Chandarana AH, Naik AM, Goyal RK |
Revascularization in acute myocardial infarction Using percusurge in distal protection (RAPID) (Abstract) |
Catheterization and
Cardiovascular Interventions 2004; 62:pg116 |
|
16 |
Parikh KH, Chag MC, Shah UG, Baxi HA,
Chandarana AH, Naik AM, Shah HD, Goyal RK |
Improvement in mace by sequential administration Of boluses of intracoronary adenosine and sodium Nitroprusside during percutaneous coronary Interventions |
Catheterization and
Cardiovascular Interventions 2004; 62:130-131 |
|
17 |
Parikh KH, Chag MC, Shah UG, Baxi HA,
Chandarana AH, Naik AM, Shah HD, Shah KJ, Shah JN, Goyal RK |
Improvement in mace by sequential administration Of boluses of intracoronary adenosine and sodium Nitroprusside during percutaneous coronary Interventions |
Poster Presentation at
Annual Congress, European Society of Cardiology, 2004 |
|
18 |
Chag MC, Parikh KH, Shah UG, Baxi HA,
Chandarana AH, Naik AM, Shah JN, Shah HD, Shah KJ, Goyal RK |
Increased
lipoprotein as a strong risk factor for Coronary artery
disease and the effect or niacin Amongst Indians. |
Oral Presentation at 56th annual
conference of the Cardiological Society of India (CSI) at |
|
19 |
Chag MC, Shah HD, Joshi MV, Parikh KH, Shah
UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK |
Renal artery
stenting is safe and effective modality Of treatment on
mid term follow up |
Poster presentation at 56th
Annual Conference of The Cardiological Society of India (CSI) at |
|
20 |
Shah KJ, Chag MC, Parikh KH, Goyal RK |
Homocysteine
and Coronary Artery Disease |
Indian Journal of Pharmaceutical Sciences;Vol 66;2004;595-601 |
|
21 |
Shah
HD, Iyer S, Shah K, Parikh K, Chag M, Shah U, Baxi H, Chandarana A, Naik A,
Goyal RK |
Effect of Statins in combination with fenofibrate
in patients after percutaneous transluminal coronary angioplasty |
Indian Journal of Pharmacology, 2004; 36(2): pg
113 |
|
22 |
Shah K J, Parikh K H |
Molecule of the Millennium Bosentan in Primary
Pulmonary Hypertension |
Indian Journal of Pharmacology; 2004;Vol 36:2;118 |
|
23 |
Mehta K N, Parikh
K H, Chag MC, Shah U G, Baxi H A,
Chandarana A H, Naik A M, Goyal R K |
Effect of Folate
Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study |
Indian Journal of
Pharmacology;2005;Vol 37:13-17 |
|
24 |
Shah K J, Iyer S
S, Parikh K H, Goyal R K |
Dual RAAS
Blockade with ACE-I and ARB (Review) |
Indian Journal
of Cardiology |
|
25 |
Shah HD, Parikh KH, Chag MC, Shah UG, Baxi
HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK |
Association of
White Blood cell count with the Occurrence of
slow/no reflow in acute coronary Syndrome patients
undergoing PCI |
Poster presentation at Joint International
Conference of ISHR and IACS, Jan 2005, |
|
26 |
Shah HD, Parikh KH, Goyal RK |
Recent
Trends in Antiplatelet Therapy for Acute Coronary Syndromes: Glycoprotein Iib/IIIa
receptor antagonists |
Gupta SK, Pawan Singhal PK, Agrawal SS , Pharmacotherapy of Heart failure, Ch 8,102:22, 2005 |
|
27 |
Shah HD, Parikh KH, Chag MC, Shah UG, Baxi
HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK |
Efficacy of
Percusurge Guardwire system in acute Myocardial
patients undergoing Primary/rescue PCI. |
Oral Presentation at Joint International Conference of ISHR and IACS,
Jan 2005, |
|
28 |
Parikh KH, et al. |
Development of
Group Practice in Cardiology, Financial planning and Research and development |
CSI Book 2005 |
|
29 |
Kanan Shah, Keyur Parikh, Milan Chag, Urmil
Shah, Anish Chandarana, Hemang Baxi, Ajay Naik, Ramesh K. Goyal |
A vigilance study
of distal protection device used during Percutaneous
coronary interventions |
International Journal of Risk & Safety
in Medicine 18 (2006) 205-212. |
|
30 |
KH Parikh, HA Shah, UG Shah, HA Baxi, AH
Chandarana, AM Naik, JN Shah, MP Tanna, MC Chag |
Initial Clinical
experience with Bivalirudin as an anticoagulant during percutaneous coronary
interventions in Asian Indian patients. |
Presented at
Annual Conference of The Cardiological Society of |
|
31 |
KH Parikh, HA
Shah, JN Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, RK Goyal, MC Chag |
Prospective
randomized study of PercuSurge in Acute Myocardial Infarction Patients
undergoing Revascularization with a special Emphasis on Procedural Time: A
Two Year Follow-up. |
Presented at
Annual Conference of The Cardiological Society of |
|
32 |
Chandarana AH,
Shah JN, Shah HA, Shah UG, Baxi HA, Naik AM, Joshi M, Goyal RK, Parikh KH,
Chag MC. |
High Prevalence
Of Renal Artery Stenosis In Hypertensive Patients With Triple Vessel Coronary
Artery Disease: Recommendation For Simultaneous Renal Arteriogram For Earlier
Intervention. |
Presented at
Annual Conference of The Cardiological Society of |
|
33 |
HA Shah, JN Shah,
AH Chandarana, MC Chag, UG Shah, HA Baxi, AM Naik, KH Parikh, RK Goyal. |
Association
between the White Blood Cell Count and Occurrence of Slow or No Reflow
Phenomenon in Patients with Acute Coronary Syndromes in the coronary
Interventional Era. |
Presented at
Annual Conference of The Cardiological Society of |
|
34 |
HA Shah, MC Chag, MP Tanna, UG Shah, HA Baxi, AH
Chandarana, AM Naik, JN Shah, KH Parikh. |
Incidences and
Clinical Characteristics of No Reflow after Percutaneous Coronary
Interventions in High Risk Asian Indian Patients. |
Presented at
Annual Conference of The Cardiological Society of |
|
35 |
Dr. Keyur H. Parikh |
Using the Remon
Pressure Device: One Year Follow-up. |
Presented at
Innovations in Cardiovascular Interventions (ICI), |
|
36 |
K. Parikh, AM
Naik, HA Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, JN Shah, A |
First In Man: Direct Comparison Of Conventional
Coronary Sinus Angiography And CT Angiography For Visualization And Sizing Of
Coronary Sinus |
Presented at TCT-
October 2006, |
|
37 |
K. Parikh, HA
Shah, AH Chandarana, AM Naik, MC Chag, UG Shah, HA Baxi, JN Shah, A |
First In Man: Multislice CT Angiography
Visualization Of An Innovative First-in-man Coronary Sinus Reducer Stent In
Patients With Refractory Angina |
Presented at TCT-
October 2006, |
|
38 |
Parikh KH, Shah HA |
A year in
Percutaneous Interventions |
Published In Cardiology Update 2006 |
|
39 |
Parikh KH, Shah HD,
et al. |
Stem cell Therapy
in ACS; Type, Timing and Promise |
The Post-Graduate
Medicine, 2006 |
|
40 |
K. Parikh, HA. Shah, AM. Naik, HA. Baxi, MC. Chag, AH. Chandarana, A. Hjalmarson, Y. Rozenman |
Presented at ESC-World Congress of Cardiology 2006, |
|
|
41 |
K. Parikh, HA. Shah, AM. Naik, HA. Baxi, MC. Chag, UG. Shah, A.
Hjalmarson, Y. Rozenman |
Presented at ESC-World Congress of Cardiology 2006, |
|
|
42 |
K. Parikh, HA. Shah, AM. Naik, HA. Baxi, MC. Chag, AH. Chandarana, A. Hjalmarson, Y. Rozenman |
Presented at ESC-World Congress of Cardiology 2006, |
|
|
43 |
K. Parikh, AM. Naik, HA. Shah, HA. Baxi, MC. Chag, UG. Shah, AH. Chandarana, Y.
Rozenman |
|
Presented at ESC-World Congress of Cardiology 2006, |
|
44 |
MC. Chag, HA. Shah, AM. Naik, HA. Baxi,
UG. Shah, AH. Chandarana, Y. Rozenman, KH. Parikh |
Presented at ESC-World Congress of Cardiology 2006, |
|
|
45 |
H. Shah, RK. Goyal, AM. Naik, HA. Baxi, MC.
Chag, A. Hjalmarson, Y. Rozenman, KH. Parikh |
Presented at ESC-World Congress of Cardiology 2006, |
|
|
46 |
Parikh KH, shah
HP, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F,
H Jalmanson A, Razenman Y |
First in man:
Papirus-monitoring Pulmonary artery Pressure by Implantable device
Responsible to Ultrasonic signals. |
Oral Presentation
at the Late Breaking Clinical Trials Session at the ACC-i2 summit, ACC
Conference, March-12, 2006 |
|
47 |
Banai S, Keren G,
Sievert H, Seth A, Ben Muvhar S, Naik AM, Medina A, Chandra P, Shah H, Parikh
KA. |
First-in-man:
Coronary sinus Narrowing with a reducer stent- A possible alternative
Percutaneous treatment for patients with refractory angina. |
Presented in
Poster session at ACC Conference on March 12, 2006. |
|
48 |
Parikh KH, shah
HP, Naik AM, Chag MC, Shah US,Baxi HA, Chandarana AH, Shah JN, Waagstein F, H
Jalmanson A, Razenman Y. |
Effect of
Metoprolol XL on pulmonary artery pressure in patients with heart failure
measured using first in human implantable Device responding to ultrasonic
signal. |
Presented in
Poster session at ACC Conference on March 12, 2006. |
|
49 |
Parikh KH, shah
HP, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F,
H Jalmanson A, Razenman Y. |
First in man
implanted device in pulmonary artery using acoustic telemetry based on
non-invasive ultrasound activation and communication |
Presented E.
Poster presentation at ACC conference I 2 summit, March 11-14, 2006. |
|
50 |
Shah HD, Goyal
RK, Parikh KH. |
Intraconory
Boluses of Adenosine and Sodium Nirtoprusside in combination Reverses Slow/No
Reflow During Angioplasty: A Clinical Scenario of Experimental
Pre-conditioning. |
Oral and poster
presentation for Young Investigators Award Competition at ACC Conference on
March 13, 2006 |
|
51 |
Parikh KH, Shah
HD, Naik AM, Chag MC, Shah |
Effect of
Metaprolol XL on Diurnal variation in pulmonary arterial pressure in Heart
failure patients using first-in-man implantable device responding to
ultrasonic signals. |
Presented in
Poster session at ACC Conference on March 14, 2006. |
|
52 |
Hetal A Shah, Ajay M Naik,
Hemang A Baxi, Milan C Chag, Urmil G Shah, Anish H Chandarana 2, Ramesh K. Goyal, Yoseph Rozenman, Keyur H Parikh |
First-in-man:
effect of Metoprolol CR/XL uptitration on pulmonary artery pressure and its
variation in chronic heart failure monitored non-invasively by an implanted
device using ultrasonic signals |
Selected for ORAL
presentation at ESC Congress 2007 |
|
53 |
Yoseph Rozenman,
Robert S, Schwartz, Hetal Shah, Keyur H. Parikh |
Wireless Acoustic
Communication With a Miniature Pressure Sensor in the Pulmonary Artery for
Disease Surveillance and Therapy of Patients With Congestive Heart Failure |
J. Am. Coll. Cardiol; 2007; 49: 784 – 789 |
|
54 |
Shmuel Banai, Shmuel Ben
Muvhar, Keyur H Parikh, Aharon Medina, Horst Sievert, Ashok Seth, Jonathan
Tsehori, Yoav Paz, Ami Sheinfeld, Gad Keren |
Coronary
Sinus Reducer-Stent for the Treatment of Chronic Refractory Angina Pectoris:
A prospective, open label, multi-center safety feasibility first-in-man
study. |
J. Am. Coll. Cardiol 2007;
49:1783-1789. |
|
55 |
Parikh KH, Chag
MC, Shah KJ, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD,
Goyal RK |
Intracoronary
boluses of adenosine and sodium nitroprusside in combination reverses
slow/no-reflow during angioplasty: a clinical scenario of ischemic
preconditioning. |
Can J Physiol Pharmacol.
2007 Mar-Apr; 85 (3-4):476-82. |
|
56 |
Shah HD, Parikh
KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Iyer
S, Goyal RK |
Beneficial Effects
Of Addition Of Fenofibrate To Statin Therapy In Patients with
Acute Coronary Syndrome After Percutaneous Coronary Interventions. |
Exp Clin Cardiol 2007, 12: 91-6 |
|
57 |
Goyal
RK, Parikh KH, Shah HA |
An
Overview on the Management of Chronic Refractory Angina Pectoris |
Proceedings of
International Symposium on RACS 2008; Page 135-153 |
|
58 |
Goyal
RK, Parikh KH, Shah HA |
First
–In-Man Clinical Trials in |
CV network online
2007; 6: 44-7 |
|
59 |
Parikh KH, Shah
HA |
Investigational
Treatments and future directions in heart failure |
Cardiology
Today 2007; 12: 96-103 |
|
60 |
Parikh KH, Tanna MT, Shah HA, Shah AR |
Basics of Stem Cell
Therapy in Heart Failure |
Cardiology
Today 2007; 12: 104-114 |
|
61 |
Parikh KH, Shah
HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK |
Efficacy of
PercuSurge in Acute myocardial Infarction patients undergoing
Revascularization with a special emphasis on Procedural time |
Indian
Heart Journal March April 2008, Volume 60, No. 2 |
|
62 |
Nakul
Sinha, Keyur Parikh, Jaysheel B. Gangaiah, Alok Chaturvedi |
Randomized, Multi-centric, Open Label Study
To Evaluate Safety And Efficacy Of Faximab®, A Biosimilar
Abciximab In Indian Patients Undergoing Percutaneous Coronary Intervention |
Submitted to Indian Heart
Journal in August 2008 |
|
63 |
Parikh
KH, Chag Milan, Shah Anuja, Segev Amit |
Ovalum CiTopTM: A Novel
Guidewire for crossing Chronic Total Occlusion in Coronary Artery Disease
patients – First-in-Man Experience |
Published in
EUROINTERVENTION –August 2008 |
|
64 |
Keyur
Parikh, Milan Chag, Urmil Shah, Anish Chandarana, Hemang Baxi, Satya Gupta,
Ashok Seth, Pravin Chandra |
First in Man: Pilot study to evaluate the
safety and performance of Diamondback 360° TM
Orbital Atherectomy System in treating de novo calcified coronary
lesions-ORBIT I |
Submitted to TCT,2008 as
Late Breaking Trial |
|
65 |
Keyur Parikh, Jagdish Hiremath, S Thanikachalam, S. Shanmugasundaram,
Sudhakar Bangera, Leland Shapiro, Gregory Pott, Cindy Vnencak-Jones, Norbert
Voelkel, Carl Arneson, Michael Wade, R James White |
Exercise improvement and plasma
biomarker changes during IV treprostinil therapy for pulmonary arterial
hypertension: a placebo-controlled trial |
Submitted to publish in Journal
of Cardiovascular Pharmacology |
|
66 |
Ashok Seth, Nakul Sinha, Keyur Parikh, Tejas Patel, MS Hiremath, AB
Mehta, Praveen Chandra, Brian Pinto, KK Sethi, Sengottuvelu |
Safety and Efficacy of Indigenously
Developed and Manufactured Bivalirudin in Moderate/High-Risk Indian Patients
Undergoing Percutaneous Coronary Intervention: The Bivaflo Registry |
Indian
Heart Journal July-Aug 2008, Volume 60, No. 4 |
|
67 |
Keyur H Parikh |
First Report of a pilot study of orbital
atherectomy in de novo calcified coronary lesions |
Accepted
in TCTMD in Oct. 2008 (www.tctmd.com) |
|
68 |
Keyur H Parikh |
FIM Coronary CTO Results |
Accepted
in TCTMD in Oct. 2008 (www.tctmd.com) |
|
69 |
Keyur H Parikh |
PAPIRUS Monitoring Pulmonary Artery
Pressure by the Implantable Device Responding to Ultrasonic Signals-Two Year
Follow Up |
Accepted
in TCTMD in Oct. 2008 (www.tctmd.com) |
|
70 |
Bernard Chevalier, Martine Gilard, Irene Lang, Philippe Commeau, John Roosen, Michel Hanssen, Thierry Lefevre, Didier Carrié, Antonio Bartorelli, Gilles Montalescot, Keyur Parikh |
Systematic primary aspiration in acute myocardial percutaneous
intervention: a multicentre randomised controlled trial of the export
aspiration catheter |
Interventional
Cardiology of the European Society of Cardiology. 01/09/2008; 4(2):222-8. |
|
71 |
Parikh
KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK,
Rozenman Y, Hjalmarson A |
Effect of Metoprolol CR/XL on Pulmonary
Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted
Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise
Capacity |
Published
in Indian Heart Journal Volume 61 No. 1, January-February 2009 |
|
72 |
Keyur Parikh, Ashok Seth, Hemang Baxi, Anish Chandarana, Satya Gupta,
Urmil Shah, Milan Chag, Sandhya Nair, Praveen Chandra |
First In Man Assessment of Orbital
Atherectomy System in Treating De Novo Calcified Coronary Lesions (ORBIT I) |
Presented in i2 Summit ACC
2009 |
|
73 |
Keyur Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chanadarana,
Ajay Naik, Satya Gupta, Shmuel Banai |
Long Term Safety, Angina Relief and
Improvement in Quality of Life in Patients with Refractory Angina Treated
with the Neovasc Coronary Sinus Reducer |
Presented in i2 Summit ACC
2009 |
|
74 |
Keyur Parikh, Milan Chag, Amit
Segev, Anuja Shah |
FIM Study: The Ovalum CiTop Expander
guidewire for recanalisation of coronary CTOs |
Published in Euro
Intervention Supplement E Volume 5 May 2009 |
|
75 |
|
Outcome
with ticagrelor versus clopidogrel in acute coronary syndromes in relation to
renal function- Results from the PLATelet inhibition and patient Outcomes (PLATO)
Trial |
Submitted in Circulation
in March 2010 |
|
76 |
Ian Meredith,
MBBS, PhD, FACC * ; Martin Rothman, MB, ChB, FESC, FACC, FRCP†; |
Safety and Effectiveness of
the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice:
Extended 2-Year Follow-up from the E-Five Registry |
Submitted: JACC
Interventions |
|
77 |
Robert A. Harrington, M.D.,
Gregg W. Stone, M.D., Steven McNulty, M.S., Harvey D. White, D.Sc., A.
Michael Lincoff, M.D., C. Michael Gibson, M.D., Charles V. Pollack, Jr.,
M.D., Gilles Montalescot, M.D., Ph.D., Kenneth W. Mahaffey, M.D., Neal S.
Kleiman, M.D., Shaun G. Goodman, M.D., Maged Amine, M.D., Dominick J.
Angiolillo, M.D., Ph.D., Richard C. Becker, M.D., Derek P. Chew, M.B., B.S.,
M.P.H., William J. French, M.D., Franz Leisch, M.D., Keyur H.
Parikh, M.D., Simona Skerjanec, Pharm.D., and Deepak L. Bhatt,
M.D., M.P.H. |
P2Y12 Inhibition with
Cangrelor Compared with Clopidogrel in ACS Patients Undergoing PCI: CHAMPION
PCI Results |
Published at www.nejm.org November 15,
2009 (10.1056/NEJMoa0908628) |
|
78 |
Edoardo Camenzind, MD, William Wijns,
MD, Laura Mauri, MD,cEric Boersma, PhD, Keyur Parikh, MD, Volkhard Kurowski,
MD, Runlin Gao, MD, Christoph Bode, MD,h John P. Greenwood, PhD, Anthony
Gershlick, MD,William O’Neil, MD, Patrick W. Serruys, MD, PhD,l Brenda
Jorissen, PhD, and Gabriel P. Steg, MD, |
Rationale and design of the Patient
Related Outcomes with Endeavor versus Cypher stenting
Trial (PROTECT): Randomized controlled trial comparing
the incidence of stent thrombosis and clinical events
after sirolimus or zotarolimus
drug-eluting stent implantation |
Article in Press; American Heart Journal-2009 |
|
79 |
Jagdish Hiremath, MD, S. Thanikachalam,
MD, Keyur Parikh, MD, (The Heart Care Clinic, Ahmedabad, India), S.
Shanmugasundaram, MD, Sudhakar Bangera, MD, Leland Shapiro, MD, Gregory B.
Pott,PhD, Cindy L.Vnencak-Jones PhD |
Exercise improvement and plasma biomarker
changes with intravenous treprostinil therapy for pulmonary arterial
hypertension: A placebo-controlled trial (TRUST – 2) |
Published in The Journal of Heart and Lung
Transplantation |
|
80 |
Patel HR, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA |
Study to Evaluate Safety
and Efficacy of Bare Metal Stent and Zotarolimus Eluting Stent |
Poster Session at the 61st
Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the |
|
81 |
Bhanushali SM, Patel VD Ghatak SB, Patel MV, Daniel PS, Parikh
KH, Bhatt PA |
To evaluate the
comparative efficacy of angiotensin receptor blocker in acute coronary
syndrome patients following medicated and non-medicated coronary stent
implantation. |
Poster Session at the 61st
Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the |
|
82 |
Patel VD, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA |
Triple versus dual
antiplatelet therapy following coronary stenting: Impact on lipid profile |
Poster Session at the 61st
Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the |
|
83 |
Patel JM, Patel HR,Patel MV, Ghatak SB, Anand IS, Parikh KH,
Bhatt PA |
Pharmacoeconomic analysis,
clinical outcomes and quality of life assessment between medication therapy
and drug eluting stent in single vessel blockade patients |
Poster Session at the 61st
Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the |
|
84 |
Parloop Bhatt, Manoj Patel, Somsuvra
Ghatak, Keyur Parikh |
Reinventing the phases of clincal trial |
Pharmaceutical Reviews, in press |
|
85 |
Camenzind E, Steg PG, Parikh K, Kurowski V, Gao R, Bode C, Greenwood JP,
Gershlick A, Boersma E, Mauri L, O'Neill W, Serruys PW, Wijns W |
Baseline Clinical and Angiographic Characteristics of the Patient Related
Outcomes WiTh Endeavor Versus Cypher STenting (PROTECT) Trial |
Submitted To TCT 2010 |
|
86 |
Shmuel Banai, Marc Schwartz, Horst Sievert, |
Long
Term Follow-Up to Evaluate the Safety of the Neovasc Reducer A
Device-Based Therapy for Chronic Refractory Angina |
Submitted To TCT 2010 |
|
87 |
Hiren patel, Manoj Patel, I.
S.Anand, Chaman Patel, Keyur Parikh, Parloop Bhatt |
Pharmacoeconomical
comparison of bare metal stent and drug eluting stent |
Journal of Chemical and Pharmaceutical Research
Vol.2;Issue 2, 2010 |
|
88
|
Jatin Patel, Vinod Patel, Hiren
Patel, Manoj Patel, Keyur Parikh, Parloop Bhatt, Chaman
Patel, I. Anand |
Pharmacoeconomic
analysis,clinical outcomes between medication therapy and drug eluting stent
in single vessel blockade patients |
Vol.1, Issue 1, 2010 |
|
89
|
Hiren R Patel, Vinod D Patel, I S Anand, C N Patel, Keyur Parikh , Parloop Bhatt |
A study to compare clinical outcomes of bare metal and zotanolimus eluting stent |
|
|
90 |
Sandip Bhanushali, P S Daniel , I S Anand , C N Patel, Parloop Bhatt, Keyur Parikh |
The comparative efficacy of angiotensin receptor blocker in acute coronary syndrome patients following medicated and non - medica ted stent implantation. |
|
|
91 |
Vinod Patel , J M Patel , I S Anand , C N Patel , M V Patel , Keyur Parikh, Parloop Bhatt. |
Triple Versus Dual Antiplatelet Therapy Following Coronary stenting : Impact on lipid profile |
|
|
92 |
Keyur Parikh |
Cangrelor Decreases Myocardial Damage In acute coronary syndrome patients invasively managed when cardiax enzymes are rising prior to PCI: Insights from the CHAMPION Trials |
|
|
93 |
Keyur Parikh |
Editorial : A quarter century of direction - Femoral approach towards extinction. |
|
|
94 |
Keyur Parikh |
Guest Editorial |
|
|
95 |
Keyur Parikh, Parikh Roosha |
Guidelines (and Advisory ) for doctors and surgeons to mange anti- thrombotic agents in patients with drug eluting and bare metal stents undergoing non cardiac surgery. |
|
|
96 |
Naik Ajay , Gupat Satya, Baxi Hemang, Shah Urmil, Keyur Parikh, Chandarana Anish, Chag Milan |
Remon CHF : Better Care for Congestive Heart Failure Patients |
|
|
97 |
Naik Ajay , Gupat Satya, Baxi Hemang, Shah Urmil, Keyur Parikh, Chandarana Anish, Chag Milan
|
Neovasc coronary sinus reducer: The time tested option for " No option " patients. |
Issue 7 Volume 5,July 2010 |
|
98 |
Parikh Keyur , Pandya Nilesh, Baxi Hemang, Chag Milan , Gupta Satya, Chandarana Anish, Naik Ajay , Shah Urmil |
The principal investingator of ORBIT I trial discusses safety and performance of diamondback 360 TM orbital atherectomy system in treating de novo calcified coroanry lesions |
|
|
99 |
Chag Milan, Panchal Kanaiya, Baxi Hemang, Chandarana Anish, Ajay Naik, Shah Urmil , Parikh Keyur |
Initial Experience with CiTop expander guidewire in chronic coronary total occlusion |
|
|
100 |
Chag Milan, Gupta Satya, Chandarana Anish, Shah Urmil, Baxi Hemang, Parikh Keyur |
Transradial Interventions : our experience |
|
|
101 |
Nanjundappa Arvind, Siddiqui Yaha, Thompson Stephanie, Keyur Parikh |
Blood transfusion : Benefit or Harm? Allogenic Blood Transfusion related mortality in the cardiovascular patient |
|
|
102 |
Keyur Parikh |
Perspective |
|
|
103 |
Stefan James, Andrzej Budaj, Philip Aylward, Kristen K. Buck, Christopher P. Cannon, Jan H. Cornel, Robert A. Harrington, Jay Horrow, Hugo Katus, Matyas Keltai, Basil S. Lewis, Keyur Parikh; Robert F. Storey, Karolina Szummer, Daniel Wojdyla, Lars Wallentin |
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial |
|
|
104 |
Keyur Parikh |
Pre treatment with thienopyridines reduces the amount ofmyonecrosis in acute coronary syndrome patients invasively managed : insights from the champions trials. |
|
|
105 |
Sergio Leonardi, Amanda Stebbins. Renato D. Lopes , Yuliya Lokhnygina , Deepak L. Bhatt, Gregg W. Stone, Michael A. Lincoff, Harold L. Dauerman , C.Michael Gibson, Harvey D. White, Keyur Parikh , Luis Gruberg, Howard C. Herrmann, Brent T.McLaurin, Shaun Goodman, Robert A. Harrington, Kenneth W. Mahaffey. |
Maintenance Therapy with Thienopyridines May Reduce Enzymatic Infarct Size In Patients with Acute Coronary Syndrome Undergoing PCI : Insights From The CHAMPION PCI Trail |
|
|
106 |
Satya Gupta,Abhi Patangay, Promadsingh Thakur, Elisa Vireca,Ajay Naik, Hemang Baxi, Urmil Shah, Anish Chandarana, Keyur Parikh. |
Third Heart Sounds Measured at CRT Device Implant Sites are Correlated to Echocardiographic Filling Parameters in Ambulatory Heart Failure Patient.
|
|
INVITED GUEST EDITORSHIP
v
Transradial Coronary Angioplasty: Where are
we today? What are future directions, consensus 2010-a special issue published
by Indian heart Journal
v
Gujarat Medical Journal on Cardiology-a
special issue published by Indian Medical Association(